Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
7.01
0.00 (0.00%)
Jun 4, 2025, 3:05 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Albumin - Imported | 3.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Albumin - Imported Growth | 28.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Intravenous Injection | 1.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Intravenous Injection Growth | 37.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Albumin - Self-produced | 1.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Albumin - Self-produced Growth | -3.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Blood Products | 1.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Blood Products Growth | 11.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Testing Equipment and Reagents | 141.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Testing Equipment and Reagents Growth | 131.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business | 1.57M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Business Growth | 19.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Albumin | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Albumin Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 7.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 21.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|